174 related articles for article (PubMed ID: 23965380)
1. Menthol inhibits 5-HT3 receptor-mediated currents.
Ashoor A; Nordman JC; Veltri D; Yang KH; Shuba Y; Al Kury L; Sadek B; Howarth FC; Shehu A; Kabbani N; Oz M
J Pharmacol Exp Ther; 2013 Nov; 347(2):398-409. PubMed ID: 23965380
[TBL] [Abstract][Full Text] [Related]
2. The effect of Δ9-tetrahydrocannabinol on 5-HT3 receptors depends on the current density.
Yang KH; Isaev D; Morales M; Petroianu G; Galadari S; Oz M
Neuroscience; 2010 Nov; 171(1):40-9. PubMed ID: 20800662
[TBL] [Abstract][Full Text] [Related]
3. The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes.
Yang KH; Galadari S; Isaev D; Petroianu G; Shippenberg TS; Oz M
J Pharmacol Exp Ther; 2010 May; 333(2):547-54. PubMed ID: 20160007
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of peppermint oil and (-)-menthol with respect to 5-HT3 receptor subtypes: binding studies, cation uptake by receptor channels and contraction of isolated rat ileum.
Heimes K; Hauk F; Verspohl EJ
Phytother Res; 2011 May; 25(5):702-8. PubMed ID: 21077259
[TBL] [Abstract][Full Text] [Related]
5. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.
Oz M; Zhang L; Morales M
Synapse; 2002 Dec; 46(3):150-6. PubMed ID: 12325042
[TBL] [Abstract][Full Text] [Related]
6. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
7. Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors.
Mahgoub M; Keun-Hang SY; Sydorenko V; Ashoor A; Kabbani N; Al Kury L; Sadek B; Howarth CF; Isaev D; Galadari S; Oz M
Eur J Pharmacol; 2013 Nov; 720(1-3):310-9. PubMed ID: 24140434
[TBL] [Abstract][Full Text] [Related]
8. Competitive antagonism of the mouse 5-hydroxytryptamine3 receptor by bisindolylmaleimide I, a "selective" protein kinase C inhibitor.
Coultrap SJ; Sun H; Tenner TE; Machu TK
J Pharmacol Exp Ther; 1999 Jul; 290(1):76-82. PubMed ID: 10381762
[TBL] [Abstract][Full Text] [Related]
9. Natural compounds boldine and menthol are antagonists of human 5-HT3 receptors: implications for treating gastrointestinal disorders.
Walstab J; Wohlfarth C; Hovius R; Schmitteckert S; Röth R; Lasitschka F; Wink M; Bönisch H; Niesler B
Neurogastroenterol Motil; 2014 Jun; 26(6):810-20. PubMed ID: 24708203
[TBL] [Abstract][Full Text] [Related]
10. Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriers.
Walkembach J; Brüss M; Urban BW; Barann M
Br J Pharmacol; 2005 Oct; 146(4):543-52. PubMed ID: 16041395
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the 5-HT3A receptor-mediated current by alkyl 4-hydroxybenzoates isolated from the seeds of Nelumbo nucifera.
Youn UJ; Lee JH; Lee YJ; Nam JW; Bae H; Seo EK
Chem Biodivers; 2010 Sep; 7(9):2296-302. PubMed ID: 20860031
[TBL] [Abstract][Full Text] [Related]
12. Capsaicin Is a Negative Allosteric Modulator of the 5-HT
Nebrisi EE; Prytkova T; Lorke DE; Howarth L; Alzaabi AH; Yang KS; Howarth FC; Oz M
Front Pharmacol; 2020; 11():1274. PubMed ID: 32982728
[TBL] [Abstract][Full Text] [Related]
13. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
Solt K; Stevens RJ; Davies PA; Raines DE
J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
[TBL] [Abstract][Full Text] [Related]
14. Subunit-dependent inhibition and potentiation of 5-HT3 receptor by the anticancer drug, topotecan.
Nakamura Y; Ishida Y; Yamada T; Kondo M; Shimada S
J Neurochem; 2013 Apr; 125(1):7-15. PubMed ID: 23305320
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 5-HT(3) receptors-activated currents by cannabinoids in rat trigeminal ganglion neurons.
Shi B; Yang R; Wang X; Liu H; Zou L; Hu X; Wu J; Zou A; Liu L
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):265-271. PubMed ID: 22528232
[TBL] [Abstract][Full Text] [Related]
16. The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors.
Lochner M; Thompson AJ
Neuropharmacology; 2016 Sep; 108():220-8. PubMed ID: 27108935
[TBL] [Abstract][Full Text] [Related]
17. Colchicine: a novel positive allosteric modulator of the human 5-hydroxytryptamine3A receptor.
de Oliveira-Pierce AN; Zhang R; Machu TK
J Pharmacol Exp Ther; 2009 May; 329(2):838-47. PubMed ID: 19188483
[TBL] [Abstract][Full Text] [Related]
18. Local anesthetics have different mechanisms and sites of action at recombinant 5-HT3 receptors.
Ueta K; Suzuki T; Sugimoto M; Uchida I; Mashimo T
Reg Anesth Pain Med; 2007; 32(6):462-70. PubMed ID: 18035290
[TBL] [Abstract][Full Text] [Related]
19. A role for the Val291 residue within the transmembrane domain 2 in diltiazem- and TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester]-mediated 5-hydroxytryptamine type 3A receptor regulations.
Lee BH; Choi SH; Pyo MK; Shin TJ; Hwang SH; Kim BR; Lee JH; Rhim H; Kim HC; Nah SY
Biol Pharm Bull; 2009 May; 32(5):861-7. PubMed ID: 19420755
[TBL] [Abstract][Full Text] [Related]
20. Bupropion Inhibits Serotonin Type 3AB Heteromeric Channels at Clinically Relevant Concentrations.
Stuebler AG; Jansen M
Mol Pharmacol; 2020 Mar; 97(3):171-179. PubMed ID: 31871303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
